CN101259242A - Medicine for treating allergic rhinitis - Google Patents
Medicine for treating allergic rhinitis Download PDFInfo
- Publication number
- CN101259242A CN101259242A CNA2008100548519A CN200810054851A CN101259242A CN 101259242 A CN101259242 A CN 101259242A CN A2008100548519 A CNA2008100548519 A CN A2008100548519A CN 200810054851 A CN200810054851 A CN 200810054851A CN 101259242 A CN101259242 A CN 101259242A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- medicine
- treatment
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention belongs to the technical field of traditional Chinese medicine, in particular to a medicine for remedying the allergic coryza, which solves the problem in the prior art that the medicine used for remedying the allergic coryza has bad curative effect. The medicine for remedying the allergic coryza is made from the following raw materials: milkvetch root, biond magnolia flower, Siberian cocklebur fruit, selfheal, stiff silkworm, baical skullcap root, earthworm, sharpleaf calargal seed, the root bark of peony tree, liquorice and Chinese date. The medicine of the present invention has the following beneficial effects of short treatment period, obvious curative effect, low treatment cost and not causing recrudescence easily.
Description
Technical field
The invention belongs to technical field of Chinese medicine, be specifically related to a kind of medicine of treatment of allergic rhinitis.
Background technology
Allergic rhinitis claims allergic rhinitis again, belongs to " allergic rhinitis " category of the traditional Chinese medical science.Be the allergic disease that occurs in nasal mucosa, the nasal mucosa reactivity increase be its main feature allergic rhinitis clinically with rhinocnesmus, sneeze, rhinorrhea, having a stuffy nose is main performance.Seasonal and catarrhus perennialis's branch is arranged clinically, is otorhinolaryngologic commonly encountered diseases, frequently-occurring disease.But the therapeutic effect of existing medicine is not good, and as commercially available XINQIN granule, its course of treatment is long, with 20 days be a course of treatment, clinical pushing away deposited 2-4 the course of treatment.
Summary of the invention
The present invention provides a kind of short treating period in order to solve the not good problem of medication effect that is used for the treatment of allergic rhinitis in the prior art, and evident in efficacy, medical expense is low, the medicine of the treatment of allergic rhinitis of the pure Chinese medicine of difficult recurrence.
The present invention adopts following scheme to realize, the medicine of treatment of allergic rhinitis is characterized in that being made by the raw material of following weight ratio: Radix Astragali 10-30 gram, Flos Magnoliae 6-15 gram, Fructus Xanthii 6-15 gram, Spica Prunellae 10-30 gram, Bombyx Batryticatus 6-15 gram, Radix Scutellariae 6-15 gram, Pheretima 5-15 gram, Fructus Alpiniae Oxyphyllae 5-10 gram, Cortex Moutan 10-30 gram, Radix Glycyrrhizae 5-10 gram, Fructus Jujubae 5-15 gram.
The medicine of treatment of allergic rhinitis is characterized in that being made by the raw material of following weight ratio: Radix Astragali 8-20 gram, Flos Magnoliae 7-12 gram, Fructus Xanthii 7-12 gram, Spica Prunellae 15-25 gram, Bombyx Batryticatus 7-12 gram, Radix Scutellariae 8-13 gram, Pheretima 7-12 gram, Fructus Alpiniae Oxyphyllae 6-9 gram, Cortex Moutan 15-25 gram, Radix Glycyrrhizae 6-9 gram, Fructus Jujubae 6-12 gram.
The medicine of treatment of allergic rhinitis is characterized in that being made by the raw material of following weight ratio: the Radix Astragali 20 grams, Flos Magnoliae 10 grams, Fructus Xanthii 10 grams, Spica Prunellae 15 grams, Bombyx Batryticatus 9 grams, Radix Scutellariae 9 grams, Pheretima 10 grams, Fructus Alpiniae Oxyphyllae 9 grams, Cortex Moutan 15 grams, Radix Glycyrrhizae 6 grams, Fructus Jujubae 10 grams.
The present invention is according to the Chinese medicine monarch, minister, and assistant makes and carries out compatibility, monarch drug Radix Astragali QI invigorating tonifying the lung spleen invigorating in the side, the expelling the toxic substance from the body with tonic skin infection, ingredient L-3 hydroxyl 9-first record stem Lignum pterocarpi indici have antibacterial action, can the human body immunity improving resistance against diseases; Contained eugenol in the Flos Magnoliae can play the effect that convergence protection nasal mucosa improves local circulation; The Fructus Xanthii pain relieving of can detoxifying, quick knot is sensible, and staphylococcus and bacillus are all had inhibitory action; Radix Scutellariae, Cortex Moutan have heat-clearing and toxic substances removing, the eliminating evil sensitive media that reduced of invigorating blood circulation discharges edema secretions; Bombyx Batryticatus, Pheretima dispelling wind and removing obstruction in the collateral can be searched the pathogenic wind unusual pathogen that picks latent lung meridian depths, to rhinocnesmus, sneeze many good effects.The Spica Prunellae detoxifcation, thereby strengthen the peripheral leukocytic phagocytic activity of human body, the human body immunity improving resistance against diseases be aided with Radix Glycyrrhizae, Fructus Jujubae adjusting T cell function, thereby the Fructus Alpiniae Oxyphyllae temperature male wind-supplying kidney reaches the effect for the treatment of both the principal and secondary aspects of a disease to the adjusting performance anti-inflammation effect of adrenal cortex function.
The method for preparing medicine of the present invention:
1, takes by weighing raw material by above-mentioned weight proportion;
2, removal of contamination is with metal device splendid attire;
3, the room temperature rinsing is 2～3 times;
4, the Radix Astragali, Radix Scutellariae, Cortex Moutan, Spica Prunellae, Radix Glycyrrhizae, Fructus Jujubae are mixed altogether decoct, one time 40 minutes, be reduced to 100-200ml after three times and be mixed in the making sheet and dry naturally with Flos Magnoliae, Fructus Xanthii, Bombyx Batryticatus, Pheretima, the Fructus Alpiniae Oxyphyllae pulverized;
5, dry the back and mix pulverizing with Chinese medicine grinder;
6, sieve with 120 orders, incapsulate.
The present invention is as follows through the clinical comparison result of the test:
The treatment group is chosen 130 routine patients and is taken two courses of treatment of Drug therapy of the present invention, 10 days each courses of treatment, cure 59 examples (49.16%): produce effects 46 examples (38.33%), the total obvious effective rate 83.33% of invalid 7 examples of effective 13 examples (10.83%) (5.83%), total effective rate 94.16%
Each symptom is organized in treatment; The integration situation of change sees Table 1 before and after the treatment, and the result shows; Treatment each symptom integral of back and total mark value are all than the decline (P＜0.01) that highly significant is arranged before the treatment
Table 1: each symptom integral variation before and after the treatment of treatment group (X ± S)
| Symptom | The example number | Before the treatment | Treated 10 days | Treated 20 days | Percentage rate | The P value |
| The rhinocnesmus sneeze | 117 | 7.05±1.47 | 2.70±.92 | .0.32±0.92 | 97.5％ | ＜0.001 |
| Rhinorrhea with clear discharge | 105 | 5.7±2.36 | 3.15±1.81 | 1.05±1.47 | 87.5％ | ＜0.001 |
| Nasal obstruction | 90 | 1.15±0.88 | 0.2±0.41 | 0.1±0.31 | 75％ | ＜0.001 |
| Headache | 65 | 0.85±0.67 | 0.45±0.51 | 0.25±0.44 | 54％ | ＜0.001 |
| Hyposmia | 57 | 1.55±0.69 | 0.95±0.39 | 0.2±0.41 | 47.5％ | ＜0.001 |
Matched group is chosen 100 routine patients and is taken the XINQIN electuary, each generation, every day three times, 20 days each courses of treatment, cure invalid 15 examples of effective 18 examples of 38 examples (38%) produce effects 29 examples (29%) (18%) (15%) obvious effective rate 67%, the integration situation of change sees Table 2 results and shows before and after the total effective rate 85%, treatment of control group; Treatment each symptom integral of back and total mark value are all than the decline (P＜0.01) that highly significant is arranged before the treatment.
Table 2: each symptom integral variation before and after the treatment of control group (X ± S)
| Symptom | The example number | Before the treatment | Treatment | Treatment | Percentage rate | The P value |
| Sneeze rhinocnesmus and play spray | 97 | 6.75±1.65 | 3.9±1.41 | 2.25±1.33 | 97％ | ＜0.001 |
| Rhinorrhea with clear discharge | 89 | 5.7±2.36 | 4.05±1.47 | 2.7±1.92 | 89％ | ＜0.001 |
| Nasal obstruction | 71 | 1.65±0.49 | 1±0.46 | 0.65±0.49 | 71％ | ＜0.001 |
| Headache | 53 | 0.9±0.31 | 0.79±0.41 | 0.7±0.47 | 53％ | ＜0.001 |
| Hyposmia | 41 | 2.35±0.49 | 1.85±0.37 | 1.2±0.7 | 41％ | ＜0.001 |
Two groups of curative effects compare, and treatment group and matched group general curative effect relatively see Table 3.
Table 3: treatment group and matched group general curative effect are relatively
| Group | The example number | Cure | Produce effects | Effectively | Invalid | Obvious effective rate | Effective percentage |
| The treatment group | 120 | 59 | 46 | 13 | 7 | 83.33％ | 94.16％ |
| Matched group | 100 | 38 | 29 | 18 | 15 | 67％， | 85％， |
Table 4: each symptom integral difference comparison before and after two groups of treatments (X ± S)
The criterion of above curative effect is; Adopt the symptom before and after the treatment of sxemiquantitative integration method statistics, sign percentage ratio changes and is divided into level Four in two courses of treatment, and cure: treatment back clinical symptoms sign disappears, and integration is reduced to " 0 "; Produce effects: treatment back clinical symptoms sign disappear substantially, the integration total value reduces 〉=60%: effectively: treatment back clinical symptoms, sign is improved, the integration total value reduces 〉=30%, and is invalid: treatment back clinical symptoms sign does not have significant change, and the integration total value reduces 30%.
Medicine of the present invention has following beneficial effect: short treating period, evident in efficacy, medical expense is low, is difficult for recurrence.
The specific embodiment
Embodiment 1:
1, presses column weight amount proportioning and take by weighing raw material.
The Radix Astragali 20 grams, Flos Magnoliae 10 grams, Fructus Xanthii 10 grams, Spica Prunellae 15 grams, Bombyx Batryticatus 9 grams, Radix Scutellariae 9 grams, Pheretima 10 grams, Fructus Alpiniae Oxyphyllae 9 grams, Cortex Moutan 15 grams, Radix Glycyrrhizae 6 grams, Fructus Jujubae 10 grams.
2, removal of contamination is with metal device splendid attire.
3, room temperature rinsing 2-3 time.
4, the Radix Astragali, Radix Scutellariae, Cortex Moutan, Spica Prunellae, Radix Glycyrrhizae, Fructus Jujubae are mixed altogether decoct, one time 40 minutes, be reduced to 100-200ml after three times and be mixed in the making sheet and dry naturally with Flos Magnoliae, Fructus Xanthii, Bombyx Batryticatus, Pheretima, the Fructus Alpiniae Oxyphyllae raw material pulverized.
5, dry the back and mix pulverizing with Chinese medicine grinder.
6, sieve with 120 orders, incapsulate.
7, medication, three times on the one, a 4-6 grain, warm water delivery service, the child reduces by half, 10 days each courses of treatment.(X±S)
Embodiment 2:
Press column weight amount proportioning and take by weighing raw material.
The Radix Astragali 10 grams, Flos Magnoliae 15 grams, Fructus Xanthii 6 grams, Spica Prunellae 10 grams, Bombyx Batryticatus 15 grams, Radix Scutellariae 6 grams, Pheretima 15 grams, Fructus Alpiniae Oxyphyllae 5 grams, Cortex Moutan 30 grams, Radix Glycyrrhizae 5 grams, Fructus Jujubae 5 grams.
Preparation process can be with reference to embodiment 1.
Embodiment 3:
Press column weight amount proportioning and take by weighing raw material.
The Radix Astragali 30 grams, Flos Magnoliae 6 grams, Fructus Xanthii 15 grams, Spica Prunellae 30 grams, Bombyx Batryticatus 6 grams, Radix Scutellariae 15 grams, Pheretima 5 grams, Fructus Alpiniae Oxyphyllae 10 grams, Cortex Moutan 10 grams, Radix Glycyrrhizae 10 grams, Fructus Jujubae 12 grams.
Preparation process can be with reference to embodiment 1.
Embodiment 4:
Press column weight amount proportioning and take by weighing raw material.
The Radix Astragali 8 grams, Flos Magnoliae 12 grams, Fructus Xanthii 7 grams, Spica Prunellae 15 grams, Bombyx Batryticatus 12 grams, Radix Scutellariae 8 grams, Pheretima 12 grams, Fructus Alpiniae Oxyphyllae 6 grams, Cortex Moutan 25 grams, Radix Glycyrrhizae 9 grams, Fructus Jujubae 6 grams.
Preparation process can be with reference to embodiment 1.
Embodiment 5:
Press column weight amount proportioning and take by weighing raw material.
The Radix Astragali 20 grams, Flos Magnoliae 7 grams, Fructus Xanthii 12 grams, Spica Prunellae 25 grams, Bombyx Batryticatus 7 grams, Radix Scutellariae 13 grams, Pheretima 7 grams, Fructus Alpiniae Oxyphyllae 9 grams, Cortex Moutan 15 grams, Radix Glycyrrhizae 6 grams, Fructus Jujubae 15 grams.
Preparation process can be with reference to embodiment 1.
Claims (3)
1, a kind of medicine of treatment of allergic rhinitis is characterized in that being made by the raw material of following weight ratio: Radix Astragali 10-30 gram, Flos Magnoliae 6-15 gram, Fructus Xanthii 6-15 gram, Spica Prunellae 10-30 gram, Bombyx Batryticatus 6-15 gram, Radix Scutellariae 6-15 gram, Pheretima 5-15 gram, Fructus Alpiniae Oxyphyllae 5-10 gram, Cortex Moutan 10-30 gram, Radix Glycyrrhizae 5-10 gram, Fructus Jujubae 5-15 gram.
2, the medicine of the described treatment of allergic rhinitis of root a tree name claim 1 is characterized in that being made by the raw material of following weight ratio: Radix Astragali 8-20 gram, Flos Magnoliae 7-12 gram, Fructus Xanthii 7-12 gram, Spica Prunellae 15-25 gram, Bombyx Batryticatus 7-12 gram, Radix Scutellariae 8-13 gram, Pheretima 7-12 gram, Fructus Alpiniae Oxyphyllae 6-9 gram, Cortex Moutan 15-25 gram, Radix Glycyrrhizae 6-9 gram, Fructus Jujubae 6-12 gram.
3, the medicine of root a tree name claim 1 or 2 described treatment of allergic rhinitis is characterized in that being made by the raw material of following weight ratio: the Radix Astragali 20 grams, Flos Magnoliae 10 grams, Fructus Xanthii 10 grams, Spica Prunellae 15 grams, Bombyx Batryticatus 9 grams, Radix Scutellariae 9 grams, Pheretima 10 grams, Fructus Alpiniae Oxyphyllae 9 grams, Cortex Moutan 15 grams, Radix Glycyrrhizae 6 grams, Fructus Jujubae 10 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100548519A CN101259242B (en) | 2008-04-17 | 2008-04-17 | Medicine for treating allergic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100548519A CN101259242B (en) | 2008-04-17 | 2008-04-17 | Medicine for treating allergic rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101259242A true CN101259242A (en) | 2008-09-10 |
| CN101259242B CN101259242B (en) | 2011-09-07 |
Family
ID=39960074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100548519A Expired - Fee Related CN101259242B (en) | 2008-04-17 | 2008-04-17 | Medicine for treating allergic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101259242B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN102698134A (en) * | 2012-05-16 | 2012-10-03 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method and application thereof |
| CN103432475A (en) * | 2013-09-06 | 2013-12-11 | 梁怡芃 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
| CN106075234A (en) * | 2016-08-08 | 2016-11-09 | 田丰 | A kind of double pungent ' Biyanwan ' for treating rhinitis |
| CN106913822A (en) * | 2017-03-12 | 2017-07-04 | 龙文凯 | Treatment rhinitis medicine without gastritis side effect and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110159A (en) * | 1994-04-12 | 1995-10-18 | 曹志刚 | Biyanan medicine for curing rhinitis |
| CN1751730A (en) * | 2004-09-20 | 2006-03-29 | 曹蛟 | Traditional Chinese medicine for treating anaphylactic rhinitis and its prepn. method |
-
2008
- 2008-04-17 CN CN2008100548519A patent/CN101259242B/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN102698134A (en) * | 2012-05-16 | 2012-10-03 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method and application thereof |
| CN102698134B (en) * | 2012-05-16 | 2014-01-01 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method and application thereof |
| CN103432475A (en) * | 2013-09-06 | 2013-12-11 | 梁怡芃 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
| CN103432475B (en) * | 2013-09-06 | 2015-03-25 | 青岛市中心医院 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
| CN106075234A (en) * | 2016-08-08 | 2016-11-09 | 田丰 | A kind of double pungent ' Biyanwan ' for treating rhinitis |
| CN106913822A (en) * | 2017-03-12 | 2017-07-04 | 龙文凯 | Treatment rhinitis medicine without gastritis side effect and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101259242B (en) | 2011-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101116733A (en) | Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis | |
| CN101259242B (en) | Medicine for treating allergic rhinitis | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN101983675A (en) | Traditional Chinese medicine composition for treating asthma and preparation method thereof | |
| CN101249208B (en) | Proprietary Chinese medicine preparations for curing chronic emphraxis lung diseases | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN101780211B (en) | Traditional Chinese medicine for treating infantile chronic cough and asthma | |
| CN115634274A (en) | Traditional Chinese medicine preparation for treating adenoidal hypertrophy of children and preparation method thereof | |
| CN109847015B (en) | Traditional Chinese medicine lotion and preparation method and application thereof | |
| CN102885946A (en) | Chinese medicament for treating cough and asthma | |
| CN1225281C (en) | Medicine for treating nasosinusitis | |
| CN102671036A (en) | Chinese medicine oral liquid for treating chronic lung abscess and preparing method thereof | |
| CN102949509A (en) | Pure traditional Chinese medical health protection syrup for clearing lung heat and stopping cough and preparation method thereof | |
| CN104523942B (en) | One treats colpitic external preparation | |
| CN105362888A (en) | Medicine for treating allergic rhinitis | |
| CN102670950B (en) | Chinese medicinal oral liquid for treating cough and preparation method thereof | |
| CN102988488A (en) | Pharmaceutical composition for treating hypertension | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN113491733A (en) | Traditional Chinese medicine composition for treating infantile cough and asthma and application thereof | |
| CN1309403C (en) | Medicinal wine having therapeutic functions for scapulohumeral periarthritis, arthritis and pains of arms and legs | |
| CN1103599C (en) | Chenxia medicament for relieving asthma and its pren. tech. | |
| CN101829286B (en) | Lung moistening and cough relieving pills | |
| CN111514215A (en) | Traditional Chinese medicine prescription for treating upper respiratory tract infection and viral pneumonia and application | |
| CN1284554C (en) | Medicine for treating acute urticaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110907 Termination date: 20150417 |
|
| EXPY | Termination of patent right or utility model |